Angiogenesis inhibition in metastatic colorectal cancer continuum of care

Lancet. 2023 Jul 1;402(10395):4-5. doi: 10.1016/S0140-6736(23)00867-X. Epub 2023 Jun 15.

Authors

Erika Martinelli¹, Fortunato Ciardiello²

Affiliations

¹ Dipartimento di Medicina di Precisione, Università degli Studi della Campania Luigi Vanvitelli, Napoli 80131, Italy.
² Dipartimento di Medicina di Precisione, Università degli Studi della Campania Luigi Vanvitelli, Napoli 80131, Italy. Electronic address: fortunato.ciardiello@unicampania.it.

PMID: 37331366
DOI: 10.1016/S0140-6736(23)00867-X

No abstract available

Publication types

Comment

MeSH terms

Angiogenesis Inhibitors* / therapeutic use
Bevacizumab / therapeutic use
Colorectal Neoplasms* / drug therapy
Colorectal Neoplasms* / pathology
Continuity of Patient Care
Humans
Neovascularization, Pathologic / drug therapy
Neovascularization, Pathologic / pathology

Substances

Bevacizumab
Angiogenesis Inhibitors